Sun Pharmaceutical Industries Ltd is quoting at Rs 1914.2, up 0.07% on the day as on 12:44 IST on the NSE. The stock is up 14.45% in last one year as compared to a 4.11% fall in NIFTY and a 16.43% ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Stock of Sun Pharmaceutical is in focus as the company’s shares are set to turn ex- dividend tomorrow with its final dividend ...

Bernstein initiates positive coverage on India Healthcare. Indian biopharma poised for transformative growth. Zydus, Lupin, ...

Join us on the Sun Pharma Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.

Indian batter Shreyas Iyer expressed profound gratitude to the medical professionals who saved his life after a severe spleen ...

Sun Pharma, Dr Reddy’s, Zydus and Divi’s Labs turn ex-dividend in July as pharma stocks near highs; check record dates and payouts.

The deal values Crinetics at $85 per share in cash, representing a potential upside of about 100% from the stock’s closing ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Sun Pharma expects to close the acquisition on or before 31 July 2026.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Sun Pharmaceutical ​Industries ‌on Saturday ​said ​it will acquire ⁠100% ​of ​Innovcare Lifesciences in ​a ​deal valued at ‌about ⁠2.71 billion rupees ($28.73 ​million).